Skip to main content
Premium Trial:

Request an Annual Quote

Stem Cells Push Back

The habit of putting handcuffs on human embryonic stem cell research might soon become a thing of the past, two news items point out today. Federal lawmakers want to get rid of three patents related to human embryonic stem cells, which could ease restrictions on future commercialization. In another report, the Senate will vote next month to overturn a presidential veto on federally funded new embryonic stem cell research.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.